BEVERLY HILLS, Calif. (AP) _ Capricor Therapeutics Inc. (CAPR) on Monday reported a loss of $2.5 million in its first quarter.
The Beverly Hills, California-based company said it had a loss of 8 cents per share.
The biotechnology company posted revenue of $230,500 in the period. Its adjusted revenue was $231,000.
In the final minutes of trading on Monday, the company's shares hit 43 cents. A year ago, they were trading at $1.31.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CAPR at https://www.zacks.com/ap/CAPR